Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001209191-17-023165

Director acquired 778 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hughes Thomas E. Director 2017-03-24 Grant or award +778 14,840 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hughes Thomas E. Director 2017-03-24 Grant or award · Stock Option (right to buy) +1,191 1,191 D: show line 2 in the form
Loading xslF345X03/doc4.xml…